LRRC15 anticorps (N-Term)
Aperçu rapide pour LRRC15 anticorps (N-Term) (ABIN635851)
Antigène
Voir toutes LRRC15 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- LRRC15 antibody was raised against the N terminal of LRRC15
-
Purification
- Affinity purified
-
Immunogène
- LRRC15 antibody was raised using the N terminal of LRRC15 corresponding to a region with amino acids LNISALIALRIEKNELSRITPGAFRNLGSLRYLSLANNKLQVLPIGLFQG
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
LRRC15 Blocking Peptide, (ABIN5614568), is also available for use as a blocking control in assays to test for specificity of this LRRC15 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LRRC15 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LRRC15 (Leucine Rich Repeat Containing 15 (LRRC15))
-
Autre désignation
- LRRC15
-
Sujet
- LRRC15 may contribute to regulation of cell-matrix adhesion interactions with respect to astrocyte recruitment around senile plaques in Alzheimer's disease brain. LRRC15 is induced by EWS-WT1(+KTS) in the tumor DSRCT and may play a role in cellular invasion.
-
Poids moléculaire
- 64 kDa (MW of target protein)
Antigène
-